Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Owkin

company

About

Owkin is an AI precision medicine company with a vision to find the right drug for every patient.

Details

Last Funding Type
Series A
Last Funding Money Raised
$11M
Industries
Artificial Intelligence,Biotechnology,Clinical Trials,Machine Learning,Pharmaceutical
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Owkin, Inc.

Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.

They use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes.

Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.

Owkin was co-founded by Thomas Clozel MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016.

Owkin has raised over $255 million and became a ‘unicorn’ – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$304.10M
Owkin has raised a total of $304.10M in funding over 2 rounds. Their latest funding was raised on Jun 8, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 8, 2022 Series B $50M 1 Bristol Myers Squibb Detail
Nov 18, 2021 Corporate Round $180M 1 Sanofi Detail
Jul 1, 2020 Series A $18M 2 Bpifrance
Mubadala Capital Ventures
Detail
May 7, 2020 Series A $25M 7 Bpifrance Detail
Mar 7, 2019 Series A $13M 5 Eight Roads Ventures
F-Prime Capital
Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Owkin has made 1 investments. Their most recent investment was on Apr 13, 2022, when MoonPay raised $87M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 13, 2022 MoonPay
Series A $87M Financial Services

Investors

Number of Lead Investors
Number of Investors
9
16
Owkin is funded by 16 investors. Bristol Myers Squibb and Sanofi are the most recent investors.
Investor Name Lead Investor Funding Round
Bristol Myers Squibb Yes Series B
Sanofi Yes Corporate Round
Bpifrance Yes Series A
Mubadala Capital Ventures Yes Series A
Otium Capital Yes Series A
Cathay Innovation Series A
Eight Roads Ventures Series A
F-Prime Capital Series A
GV Series A
MACSF Series A

Employee Profiles

Number of Employee Profiles
23
Owkin has 23 current employee profiles, including Advisor Olivier Elemento
Advisor
Executive
Executive
Executive